Wurin da ba a shigo dashi ba na kewaye da shi ba
A cewar wasu rahotanni, kamfanin Apple ya yi hayar gungun wasu manyan masana masana harkar duniya guda 30 a fagen nazarin halittu don kirkirar fasahar ta hanyar sauyi - na’urar auna sukari na jini ba tare da huda fata ba. An kuma bayar da rahoton cewa ana yin aikin ne a cikin dakin binciken sirri a California, nesa da babban ofishin kamfanin. Wakilan Apple sun ki bayar da sanarwa a hukumance.
Me yasa irin wannan maƙarƙashiya?
Gaskiyar ita ce halittar irin wannan na'urar, idan dai yana da gaskiya, don haka mai lafiya ga masu ciwon sukari, zai haifar da sauyi na gaske a duniyar kimiyya. Yanzu akwai nau'ikan na'urori masu motsa jini na jini wadanda ba a baki ba, akwai abubuwan ci gaba na Rasha. Wasu na'urori suna auna matakan sukari dangane da hawan jini, yayin da wasu suke amfani da duban dan tayi domin tantance karfin zafi da kuma yanayin ƙarfin fata. Amma alas, a daidaito har yanzu suna ƙasa da glucose na al'ada waɗanda ke buƙatar bugun yatsa, wanda ke nufin cewa amfani da su bai samar da mahimmancin iko akan yanayin haƙuri ba.
Wata majiyar da ba a san ta ba a cikin kamfanin, a cewar tashar talabijin ta Amurka CNBC, ta ba da rahoton cewa fasahar da Apple ke haɓaka ya dogara da amfani da na'urori masu auna firikwensin. Yakamata su auna matakin glucose a cikin jini tare da taimakon haskoki na haske da aka aika zuwa tasoshin jini ta fatar.
Idan yunƙurin Apple ya yi nasara, zai ba da fata ga ingantacciyar ci gaba a rayuwar miliyoyin mutane da ke fama da ciwon sukari, za su buɗe sababbin ci gaba a fagen binciken likitanci tare da ƙaddamar da sabon kasuwa mai mahimmanci ga mita baƙi masu lalata jini.
Ofaya daga cikin ƙwararrun masana game da haɓaka na'urorin bincike na likita, John Smith, ya kira ƙirƙirar ingantaccen glucometer wanda ba mai haɗari ba shine mafi wahalar aiki da ya taɓa fuskantarwa. Yawancin kamfanoni sun gudanar da wannan aikin, amma ba su yi nasara ba, duk da haka, yunƙurin ƙirƙirar irin wannan na'urar ba ya tsayawa. Trevor Gregg, darektan zartarwa na kamfanin DexCom Medical Corporation, ya ce a cikin wata hira da ya yi da kamfanin dillancin labarai na Reuters ya ce farashin wani yunƙurin nasara ya kamata ya kasance dala miliyan ɗari ko ma dala biliyan. Da kyau, Apple yana da irin wannan kayan aiki.
Ba ƙoƙarin farko ba
An san cewa har ma da wanda ya kafa kamfanin, Steve Jobs, yayi mafarkin ƙirƙirar na'urar firikwensin don auna sukari, cholesterol, gwargwadon ƙarfin zuciya, da haɗuwarsa cikin samfurin farko na wayoyin smartwat AppleWatch. Alas, duk bayanan da aka samo daga abubuwan da aka ci gaba to ba cikakke bane kuma an yi watsi da wannan ra'ayin na ɗan lokaci. Amma aikin bai daskarewa ba.
Wataƙila, koda masanan kimiyya a cikin dakin binciken Apple sun sami ingantaccen bayani, ba zai yiwu a aiwatar da shi ba a cikin samfurin AppleWatch na gaba, wanda ake tsammanin akan kasuwa a rabin na biyu na 2017. Dawo a cikin 2015, Shugaba na Kamfanin, Tom Cook, ya ce halittar irin wannan na’urar na bukatar yin rajista da rajista sosai. Amma Apple yana da mahimmanci kuma a layi daya tare da masanan kimiyya sun hayar da ƙungiyar lauyoyi don yin aiki akan sabuwar dabara.
Kayan fasaha na kwamfuta don magani
Apple ba shine kawai kamfanin da ba na asali ba yana ƙoƙarin shiga kasuwar kayan aikin likita. Google kuma yana da sashin fasaha na kiwon lafiya wanda a yanzu haka yana aiki akan tabarau na saduwa wanda zai iya auna karfin jini ta hanyar jijiyar ido. Tun a cikin 2015, Google ta haɗu tare da DexCom da aka ambata game da haɓakar glucometer, dangane da girman da kuma hanyar yin amfani da shi kamar patch na al'ada.
A halin da ake ciki, masu ciwon sukari a duk duniya suna aika fatan alheri ga ƙungiyar masana kimiyyar Apple kuma suna bayyana begen cewa duk marasa lafiya za su iya samun wannan na'urar, sabanin AppleWatch na yau da kullun.
Tim Cook da kaina yana gwada mit ɗin don sabon Apple Watch
Apple yana aiki da gaske akan tsararren sukarin jini wanda ba mai mamayewa ba ga Apple Watch wanda muka ambata a baya. Babban jami'in Apple Tim Cook ya tabbatar da wannan a kaikaice. Manema labarai na CNBC ne suka hangi Shugaba din suna gwajin wata na'urar da ke da alaka da kamfanin Apple Watch da kuma kwatancen mai sukarin jini.
Tim Cook, yayin da yake magana da] aliban Jami'ar Glasgow, a watan Fabrairu, ya ce, “Na] auki mitana, har tsawon makwanni. "Na cire shi kafin na sadu da ku." Babban manajan ya yi bayanin cewa malamin a lokaci-lokaci yana amsa canje-canje a jikinsa bayan ya ci abinci. Saboda haka, don guje wa sanar da samun sahihancin insulin, ya kan ci gaba da binciken.
A cewar majiyoyin CNBC a cikin kamfanin, Tim Cook yana da babban bege na mita, sabili da haka da kaina yana gwada aikinsa. Koyaya, a wannan lokacin, ma'aunin matakan glucose baya cikin agogo kuma yana aiki azaman sutturar waje. Masu kutse cikin littafin ba su bayyana yadda mai binciken ya hada kai da Apple Watch ba.
Kamfanin Apple wanda ba mai mamayewa ba shine mita glucose na jini na SmartWatch: labaran bioelectronics
Wallahi Alla 3 ga Mayu, 2017. An buga shi a Labaran Magunguna
Apple ya fara aiki akan wani aiki wanda burinsa shine ƙirƙirar mita glukos ɗin mara jini mara ƙarfi. Ana gudanar da aiki tare da sabuwar fasaha.
SmartWatch kyakyawan agogo ne wanda zai sauƙaƙa rayuwar yau da kullun na miliyoyin masu ciwon sukari kuma zai taimaka musu da sauri gano matakan sukari na jini.
Dangane da bayanin da ba a tabbatar da shi ba a hukumance, Apple ya riga ya fara aiki da sabuwar dabara don auna glucose wanda baya buƙatar samfurin jini. Wannan fasaha ta ƙunshi amfani da na'urori masu auna firikwensin da za a gina su a cikin sabon ƙarni na SmartWatch ("wayoyi masu kaifin ra'ayi" waɗanda zasu ba ka damar nunawa ba kawai lokaci ba, har ma auna adadin matakan da adadin kuzari da aka ƙone. Su ma suna da ikon maye gurbin wani wayo).
A halin yanzu, SmartWatch wasa abin wasa ne wanda yake da daɗi a sami mutane masu arziki. Mawallafin ra'ayin shine ɗayan waɗanda suka kafa Apple, Steve Jobs, wanda ya mutu shekaru shida da suka gabata daga cutar kansa. Bayan rasuwarsa, wanda zai gaje shi ya ɗauki matakin, ya fara aiki a ƙirar na'urar.
Don yin wannan, Apple ya ƙirƙiri rukuni na ƙwararrun masanan kimiyyar halittun 30 waɗanda ke da hankali a cikin karamin ofis a Palo Alto, California. Ana kiyaye ci gaba a cikin ingantaccen amincewa da alkawalin kawo sauyi kan rayuwar miliyoyin mutane a duniya.
Sun ce aiki a kan SmartWatch don auna glucose na jini ya ci gaba har tsawon shekaru 5 kuma a halin yanzu ana fuskantar gwaji a asibiti a Palo Alto Bay.
Masana na Apple suna iya kokarinsu don ganin an sami damar auna sukari na jini ta hanyar da ba ta saba wa doka ba.
Wannan yana nufin cewa sarrafa matakin glucose zai zama mai sauƙi kamar ... kallon agogon ku don duba lokacin. Zai yiwu wannan ƙirar ta samo asali ne ta hanyar amfani da na'urori masu auna firikwensin kuma zai dogara da fitilar haske ta fatar don auna matakan glucose.
Haɓaka irin wannan sabuwar fasaha sabon abu ne mai mahimmanci, kamar su na'urar inulin ta InPen.
Daya daga cikin kwararrun kwararru a fannin irin wadannan na’urori, John L. Smith ya yarda cewa wannan shine babban kalubalen kwararru da yakamata ya fuskanta a cikin aikinsa na fasaha. Kirkirar irin wannan na’ura na bukatar ba kawai aikin kwararrun masana ba, har ma da jan hankalin manyan masu saka hannun jari. An kiyasta cewa aikin zai sayi kamfanin daruruwan miliyoyin, watakila ma dalar Amurka triliyan ɗaya.
Ba abin mamaki bane, ƙwararrun ƙwararrun Apple sun keɓe don ƙirƙirar irin wannan na'urar. Yankin da ke tsakanin masana'antar harhada magunguna da fasahar likitanci ya fara zama a bayyane. Manyan kamfanoni suna haɗa ƙarfi don haɓaka kayan aiki a cikin sabon filin magani wanda aka fi sani da bioelectronics.
Wannan yana ba da zarafi don bincike da sauri da kuma kula da miliyoyin marasa lafiya da ke fama da ciwon sukari.
Idan agogon ya ƙetare dukkanin gwaje-gwaje na gaskiya kuma ya ci gaba da siyarwa, wannan zai zama juyin juya hali a cikin magani a duniya. Wannan zai amfana ba kawai masu ciwon sukari ba waɗanda ke da damar da za su iya dacewa da kula da matakan glucose na jini cikin sauƙi, har ma da mutanen da ke cikin ciwon suga, yanayin, wanda, ta haka, za su iya yin bincike tare da tsara mahimmancin magani cikin sauri kuma mafi dacewa.
Smartwatch zai zama muhimmiyar kayan aiki a cikin ganowa da kuma sarrafa ciwon sukari. Wannan na'urar zata zama da amfani musamman ga yara da mutanen da basu iya jure bayyanar jini ba kuma suna jin tashin hankali lokacin sokin yatsa.
Tabbas, Apple ba shine kawai kamfanin da ke sha'awar ƙirƙirar fasaha wanda ke ba da sauƙin auna sukarin jini ba. Google guda a cikin dakunan gwaje-gwajensa suna aiki akan ra'ayoyi gwaji daban-daban. Musamman, an gabatar da ainihin mafita don ƙirƙirar ruwan tabarau na "mai kaifin hankali" waɗanda zasu iya gwada glucose jini.
Kamfanoni da yawa suna aiki da fasaha don ƙirƙirar mita marasa glucose jini mara ƙaruwa. Amma, akasarinsu sun gaza. Shin Apple zai kasance farkon wanda ya yi nasara kuma ya canza rayuwar miliyoyin mutane a duniya? Har izuwa yanzu, sun hana bayanan hukuma game da wannan batun.
Mintaccen glucose na jini wanda ba mai cin nasara ba ya bayyana a cikin Apple Watch a cikin 'yan shekaru
lokacin karatu: minti 1
Apple har ila yau yana haɓaka mitan ba mai mamayewa ba, amma ba zai bayyana ba a kan Apple Watch a cikin shekaru masu zuwa. New York Times ce ta ruwaito wannan, inda aka ambaci wasu kafofin biyu da suka saba da shirin Apple.
Apple ya shirya gina na'urar firikwensin glucose a cikin ƙarni na farko na Apple Watch, wanda aka gabatar da shi a cikin 2015. Amma a ƙarshe, ta yi watsi da wannan ra'ayin, saboda a lokacin firikwensin har yanzu ba abin dogaro ba ne, yana buƙatar sarari da yawa kuma ya cinye makamashi mai yawa. Yanzu aiki akan glucose din mara kanjama ne mai gudana, kuma bai kamata ku dogara da bayyanarsa a cikin Apple Watch ba a shekaru masu zuwa. Mai yiwuwa, firikwensin zai buƙaci amincewa da Gudanar da Abinci da Magunguna (FDA, USFDA), wanda zai iya rikita aikin.
Majiyoyi sun ce Apple ya fara kirkirar firikwensin don ma'aunin marasa amfani da matakan glucose na jini a 'yan shekarun da suka gabata. An amince da wannan aikin ne 'yan watanni kafin mutuwarsa ta kamfanin Apple wanda ya kirkiro Steve Jobs, wanda ba ya son sa kullun yatsansa don auna glucose. Ka tuna cewa a cikin watanni na ƙarshe na rayuwarsa ya yi yaƙi ba kawai da ciwon kansa ba, har ma da ciwon sukari.
Apple Shugaba da kaina yana gwada glucometer don sababbin agogo masu kaifin hankali
An yi wa kamfanin na Apple Shugaba ba'a a shafukan sada zumunta saboda yaudarar da ya yi a lokacin Super Bowl.
Shugaban kamfanin Apple Tim Cook da kansa ya fara gwada wata na’urar mara waya wacce ke auna sukarin jini.
Apple ya riga ya ba da rahoto game da shirinta na samar da na'urar "mara jini" a cikin bazara.
Apple yana aiki da gaske akan tsararren sukarin jini wanda ba mai mamayewa ba ga Apple Watch wanda muka ambata a baya.
Majiyoyin CNBC da ba a san su ba sun sanar da cewa kamfanin ya riga ya gudanar da gwajin farko. Nauyin firikwensin, wanda aka haɗa shi cikin na'urar, ya sanya ya yiwu a lura da mai nuna alamun glucose ci gaba, yana nazarin yanayin tasoshin jini, gumi da fata. A halin yanzu, ƙungiyar injiniyoyin ilimin halittu suna aiki akan ƙirƙirar sa. Dangane da bayanin da aka samu ga masu ba da rahoto na CNBC, kamfanin Arewacin Amurka ya riga ya fara binciken likita game da kwayar cutar.
A karshen lokacin hunturu na shekarar 2015, yayin wani jawabi ga daliban jami’ar Glazko, Tim Cook ya ce yadda wani keken mitirin glucose na zamani ya taimaka masa wajen gano illolin abinci iri daban daban a matakan sukari na jini. Cook sai ya nanata cewa masu ciwon sukari dole suyi wannan kamar sau biyu a rana, don haka sabon na'urar zata zo da amfani. Kafofin watsa labarai a nan sun ba da shawarar cewa na'urar da ba a santa ba mai ɗaukar hoto ne mai ɗaukar ƙwayar jini.
Apple yana aiki akan sabon aikin don ƙirƙirar glucometer mara amfani
Tunanin halitta ba tare da hulɗa da glucometer ba Steve Jobs ne ya gabatar da shi a shekarar 2011. Shekaru 5, Apple ya jagoranci haɓaka fasaha na juyi wanda zai ba ka damar auna matakan sukari na jini ba mara-lalacewa. Kwanan nan aka ƙaddamar da sabon aiki kuma mai yiwuwa matakin ƙarshe na aiki akan aikin.
Mutanen Cupertinians sun gayyaci gungun injiniyoyi masu ilimin halitta don yin aiki tare. CNBC ta ruwaito wannan, inda aka ruwaito. Teamungiyar kwararru tana haɓaka mai ƙira na gani wanda zai iya karɓar bayanai game da matakan sukari na jini ta fata translucent. Har yanzu ba a san yadda za a gudanar da nazarin sukari ba - ana aiwatar da ci gaba ne cikin tsananin sirri.
Lokacin da aka aiwatar da aikin, kewayon samfurin Apple a cikin Foxtrot da sauran manyan shagunan da aka cika tare da sabon kayan kwalliyar wearable don kula da lafiya. Yana yiwuwa mai saiti na musamman za a gina shi a cikin wayayyun agogon Apple Watch.
Gudanar da sukari mara lamba ba tare da implants da lancets
A cikin 2015, Apple ya samu nasarar aiwatar da irin wannan aikin tare da haɗin gwiwar DexCom. Fiye da shekara guda, masu mallakar ƙirar smart smart Apple sun sami damar sarrafa matakan sukari na jini ta hanyar da ba a tuntuɓar su ba, ba tare da yatsar yatsunsu da lancets ba.
Gaskiya ne, akwai guda ɗaya "amma" - ba duk masu amfani zasu iya sa ido ba, amma masu ɗaukar kwandon kwastomomi kawai. An saka fatalwar mai santsi a cikin kitse mai ƙyalƙyali. Bayanai da aka saka daga mai shigarwar firikwensin ana aika shi zuwa firikwensin da aka haɗa zuwa cikin na'urar da muke silas. Dukkanin bayanai an nuna su a cikin aikace-aikacen da ya dace da tsarin Apple HealthKit.
Cupertinians sun yanke shawarar kada su huta a kan laurels ɗinsu kuma sun fara haɓaka firikwensin wanda zai iya ƙayyade matakin glucose a cikin jini ba tare da taimakon na'urorin da aka dasa ba. Sabbin fasaha zasu sauƙaƙe tsarin kulawa. Masu amfani da Apple Watch ba dole bane suyi wasu ayyukan micro-implant kuma su sake gano masu hankali.
Amfanin fasahar Apple shine samun dama ga duk masu mallakin agogo. Mai ilimin firikwensin na gani zai taimaka ba kawai marasa lafiya da masu ciwon sukari ba, har ma da masu amfani da ba a gano wannan cutar ba. Kullum saka idanu akan matakan sukari yana ba ku damar sanin ciwon sukari a farkon matakin kuma a lokaci don hana ci gaba da cutar.
Hanyar da ba a tuntuɓar da glucoetryry an haɓaka ba kawai ta Cupertinians ba. DexCom, wanda ya kasance tare da Apple a baya, ya yi aiki tare tare da Verilyungiyar bincike na ainihi don ƙirƙirar ruwan tabarau na lamba tare da na'urori masu motsa jiki da ke motsa jiki. Ana ci gaba da samun cigaba tun daga shekarar 2015. Kamfanin Google Inc. yana inganta aikin sabon aikin.
A cewar jaridar New York Times, Apple a halin yanzu yana aiki ne bisa tsari, ba tare da cin zarafi ba game da sukarin jinin mai amfani.
Alas, a cewar majiyoyin da ke kusa da kamfanin, zai dauki lokaci kafin a samar da irin wannan glucose din Apple mai lamba. An kirkiro tsarin ne musamman don agogon Apple Watch.
Bayan 'yan watanni da suka gabata, CNBC ta kuma tabbatar da aiki a kan mita. A cewar wasu rahotanni, Apple ya riga ya sami shirye-shirye na na'urorin da za su iya auna sukari na jini ba tare da allura da tasirin injiniyoyi a jikin mai amfani ba. Irin wannan firikwensin baya buƙatar samfurin jini don sanin matakin glucose.
Aikin masu haɓaka Apple shine gabatar da wani tsari wanda zai iya sarrafa sukarin jini gaba ɗaya rana. Bayyanar aikin glucometer a cikin Apple Watch zai zama kyauta ta gaske ga masu amfani da ke fama da ciwon sukari da kuma maganin cututtukan fata. 9to5mac
(Babu kuri'u)
Dexcom wanda ba shi da tsawan mita na glucose na jini zai yi aiki tare da Apple Watch
Dexcom a halin yanzu yana haɓaka wani aikace-aikacen smart smartch Apple wanda zai ba da izinin mita Dexcom G4 don canja wurin bayanai zuwa Apple Watch a cikin ainihin lokaci. A cewar masu haɓakawa, aikace-aikacen zai kasance a shirye lokacin da Applewat's smartwatch zai iya shiga kasuwa.
Yana da kyau a sani cewa Dexcom G4 Platinum shine sabon kayan aiki wanda ke ba ku damar auna glucose na jini akai-akai ba tare da ɗaukar jini akai-akai don bincike ba. Na'urar tana yin gwaji 12 a cikin awa daya, wato, ana yin gwajin ne a kowane minti biyar. A wannan yanayin, ana yin nazarin matakan glucose a cikin yanayin farkawa da kuma hutawa. Idan matakin sukari ya canza sosai, to, na'urar tana ba da sigina (duka sauti da rawar jiki), saboda mutum ya iya amsawa da sauri. Mutumin da ke da ciwon sukari na iya jin tsoron yin bacci a yayin karuwar alfijir na yawan sukari na jini: ana yin gwaje-gwaje 288 kowace rana.
Tsarin kansa ya ƙunshi sassa uku:
1. Mai karɓa tare da nuni. Na'urar tana da karamin girman, daidai da matsakaicin girman wayoyin komai da ruwan ka. An sanye na'urar da nuni wanda a bayyane yake a bayyane matakan sukari na jini. Don sarrafa ayyuka ta amfani da D-pad. Baturin yana tsawon kwana uku na rayuwar batir.
2. Mai lura da hankali. Wannan karamin firikwensin filastik ne wanda aka ɗora ko'ina a jikin ɗan adam, kamar yadda aka ambata a sama, kuma baya jin tsoron ruwa. Haske ne wanda ke da alhakin aunawa. Mai buƙatar firikwensin yana buƙatar canza sau ɗaya a mako (wannan cinyewa ne), kodayake wasu masu amfani suna da'awar cewa ana iya amfani dashi na dogon lokaci - har zuwa makonni 3.
3. Mai watsawa. Transmitaramin ƙaramin abu ne wanda yake watsa abubuwan karanta firgici ga mai karɓar. Ana jigilar mai watsawa a saman firikwensin.
Masu haɓaka mit ɗin sun ce bayan kamfanin smartwatch na kamfanin smartwatch ya shiga kasuwa, ana iya amfani da nuni na Apple Watch don duba bayanai game da taro na sukari na jini, wanda zai zama dole don shigar da aikace-aikacen da ya dace. A lokaci guda, agogo zai karɓi siginar daga mai ba da mita, kuma ya nuna bayanai a cikin ainihin lokaci. Duk bayanan za su kasance a kan Apple HealthKit.
AI a Apple Watch ya koyar da gano alamun farko na ciwon sukari tare da daidaito na 85%
An yi jita-jita fiye da sau ɗaya cewa Apple yana aiki akan mita ba mai mamayewa ba ga Apple Watch. Yanzu, masana kimiyya sun tabbatar da cewa mai auna bugun zuciya a cikin tsaran zamanin yanzu yana iya samun nasarar gano cutar sankarau a farkon matakan.
A cikin binciken da aka yi amfani da agogon Apple Watch da Android Wear, masu haɓaka app daga Cardiogram da Jami'ar California a San Francisco sun horar da hanyar sadarwa mai suna DeepHeart don bambance mutane masu ciwon sukari daga kashi 85% na masu lafiya.
Nazarin ya ƙunshi masu amfani da Cardiogram 14,011. Bayanin da aka samu godiya a kansu ya taimaka a cikin horar da DeepHeart, wanda yayi nazari tare da kwatanta bayanan marasa lafiya da masu lafiya. Haka kuma, ba kawai game da ciwon sukari ba ne, har ma game da hauhawar jini, tashin zuciya, tashin hankali da kuma cholesterol.
Hanyar zurfafa ilimin ilmin lissafi na yau da kullun na buƙatar ɗimbin bayani, miliyoyin misalai masu alama. Koyaya, a magani, kowane irin misali yana nuna cewa rayuwar mutum tana cikin haɗari - alal misali, waɗannan mutane ne da suka tsira daga bugun zuciya. Don magance wannan matsalar, masu binciken sunyi amfani da dabarun ilmantarwa mai zurfi na biyu-atomatik, wanda ya ba da izinin gano amfani da duk bayanan alama da ba a sani ba don ƙara daidaito.
An sami damar yin hakan ne don rahmar dake tsakanin cutar sankara da tsarin jijiyoyin kai. Sakamakon haka, DeepHeart na iya gano ciwon sukari ta hanyar mai auna bugun zuciya. Musamman, koda a farkon matakin cutar, tsarin bambance bambancen zuciya yana canzawa sosai domin a gano wannan canjin.
Amma ga glucometer din mara-mamaya don Apple Watch, wasu 'yan shekaru zasu wuce kafin aiwatar da wannan fasaha. Mai kirkirar Cardiogram Brandon Ballinger ya lura cewa kamfanin ya shirya don haɗawa cikin agogon DeepHeart idan an ƙara irin wannan firikwensin.
Cardiogram zai ci gaba da bincike a cikin wannan shugabanci a cikin 2018. Ofaya daga cikin mahimman canje-canje da aka tsara shine ƙari na DeepHeart zuwa app don tara cikakkun ƙididdiga.
Kada ku rasa labaran Apple - biyan kuɗi zuwa tasharmu ta Telegram, har zuwa tashar YouTube.
Cupertinians suna haɓaka aiki a cikin wannan shugabanci
Koma bayan bazara, bayanai suka bayyana cewa wata kungiya ta daban a cikin Apple tana aiki akan matakin sukari na jini wanda zai iya yin aikinta ba bisa ka'ida ba, wato, ba tare da huda fata ba.
Jaridar New York Times ta ruwaito game da wasu sanannun mutane guda biyu da suka fito daga sansanin Apple, 'yan Cupertinians suna matukar hazaka a wannan jagorar. Koyaya, 'yan shekaru zasu wuce kafin aiwatar da kasuwanci na wannan fasaha.
Idan kamfani ya yi nasara, Apple Watch, wanda irin wannan firikwensin yakamata ya bayyana, zai zama na'urar tilas ga masu ciwon sukari.
Makon da ya wuce, ya zama sananne cewa Apple yana aiki don ba da kyakyawan agogonsa na zamani mai kwakwalwa.
Apple yana inganta na'urori masu auna firikwensin don saka idanu mara kyau na sukari na jini
A cewar majiyar da aka sanar, Apple na haɓaka na'urori masu motsa jiki waɗanda zasu iya kula da matakan sukari na jini. Kamfanin ya hayar da ƙaramin rukuni na injiniyoyin kere-kere don yin aiki a kan wani aiki wanda zai taimaka wajen sarrafa matakan glucose ta hanyar tuntuɓar fata, maimakon yin amfani da gwaje-gwajen jini mara kyau ko kuma dabaru masu kama.
Wannan rukunin injin din yana cikin ofishi a Palo Alto, kuma ba a babban hedkwatarsa ba. A bayyane yake, injiniya sun yi aiki a kan fasahar firikwensin akalla shekaru 5. Kuma yanzu, Apple ya fara bincike game da yiwuwar kayan asibiti a cikin Yankin Bay. Kamfanin ya kuma dauki hayar masu ba da shawara don taimaka musu fahimtar ka'idojin kula da lafiya.
Babban jigon mataimakin shugaban kamfanin fasahar kayan masarufi, Johny Srouji ne ya ruwaito. A baya, Michael D. Hillman ne ya dauki nauyin wannan aikin, amma ya bar kamfanin a shekarar 2015. Consistsungiyar ta ƙunshi mutane 30, gami da ƙwararrun masana ilimin halittun da Apple ya yi haya daga manyan kamfanoni kamar Masimo Corp, Sano, Medtronic da C8 Medisensors. An fara sanin hayar wadannan ma'aikata ne a farkon shekarar da ta gabata, lokacin da jita-jitar farko ta tashi game da irin wannan ci gaban.
Ra'ayin yin amfani da na'urori masu kayan kwalliya waɗanda aka yi amfani da su don sarrafa yanayi kamar ciwon sukari an haɓaka su a lokacin Steve Jobs a matsayin Apple Shugaba. Koyaya, haɓaka fasaha wanda ke auna sukari na jini daidai ba tare da yanke fata ba ya tabbatar da cewa yana da wahala sosai. Masanin kwayar halitta John L. Smith, wanda ya wallafa wata kasida game da abubuwan da ke tattare da fahimtar glucose, ba shi da matsala a cikin aikina.
Dangane da rahotanni, fasaha ta Apple don auna glucose na jini tana wuce haske ta fatar mai haƙuri. Lura cewa Google shima yana aiki akan firikwensin kansa na jini, amma ya ɗauki wata hanya ta daban. Injiniyoyin Google suna haɓaka ruwan tabarau waɗanda aka tsara don bin matakan sukari na jini yayin da suke cikin ido. Ana amfani da na'urar kayan miya da ta dace ta hanyar Kimiyyar Rayuwa.
Ba'a ƙayyade lokacin da ci gaban na'urori masu auna sigina na Apple ba. Hakanan babu wani bayani ko za a yi amfani da firikwensin da aka shirya a matsayin wani ɓangare na na'urorin kamfanin, misali, Apple Watch ko samfuran makamantan su.
Omelon Glucometer a cikin 2: sake dubawa, farashi, umarnin
Masu masana'antar zamani suna ba da masu ciwon sukari iri-iri na na'urori don auna sukari na jini. Akwai samfuran da suka dace waɗanda ke haɗa ayyuka da yawa a lokaci ɗaya. Ofaya daga cikin irin waɗannan na'urori shine glucometer tare da ayyukan tonometer.
Kamar yadda ka sani, wata cuta kamar su cutar kanjamau tana da alaƙa kai tsaye da take hakkin tashin jini. A wannan batun, ana ɗaukar mita mitane na glucose na jini a matsayin na'ura ta duniya don gwajin sukari na jini da auna matsin lamba.
Bambanci tsakanin irin waɗannan na'urori shima ya ta'allaka ne akan cewa ba'a buƙatar samarwa jini anan, watau, ana gudanar da binciken ne ta hanyar daɗaɗɗa. An nuna sakamakon a kan na'urar dangane da karuwar jini.
Ka'idojin aiki na mitsi na glucose din jini
Devicesaukar na'urori masu mahimmanci suna da mahimmanci don yin matakan ma'auni wanda ba bisa ƙa'ida ba. Mai haƙuri yana auna karfin jini da bugun jini, sannan data nuna mahimman bayanai akan allon: an nuna matakin matsin lamba, bugun jini da alamomin glucose.
Sau da yawa, masu ciwon sukari, waɗanda suka saba da amfani da daidaitaccen glucometer, suna fara shakkar daidaito na irin waɗannan na'urori. Ko yaya, mitar glucose na jini suna da inganci sosai. Sakamakon yana kama da waɗanda aka ɗauka a cikin gwajin jini tare da na'urar ta al'ada.
Saboda haka, masu sa ido kan jini suna baka damar samun alamun:
- Hawan jini
- Yawan zuciya
- Babban sautin jijiyoyin jini.
Don fahimtar yadda na'urar ke aiki, kuna buƙatar sanin yadda tasoshin jini, glucose, da ƙwayar tsoka ke hulɗa. Ba asirce ba ne cewa glucose wani abu ne mai kuzari wanda ƙwayoyin tsoka na jikin mutum suke amfani da shi.
Don lura da gidajen abinci, masu karatunmu sunyi nasarar amfani da DiabeNot. Ganin shahararrun kayan wannan samfurin, mun yanke shawarar ba da shi ga hankalin ku.
A wannan batun, tare da karuwa da raguwa a cikin sukari na jini, sautin tasoshin jini yana canzawa.
Sakamakon haka, akwai karuwa ko raguwa a cikin karfin jini.
Fa'idodin amfani da na'urar
Na'urar tana da fa'idodi masu yawa idan aka kwatanta da na yau da kullun na'urori don auna sukari na jini.
- Tare da amfani da na'urar yau da kullun, haɗarin haɓaka rikice rikice ya ragu da rabi. Wannan ya faru ne saboda gaskiyar cewa ana aiwatar da ƙarin ma'aunin jini na yau da kullun kuma ana sarrafa yanayin yanayin mutum.
- Lokacin sayen na'ura ɗaya, mutum zai iya adana kuɗi, tunda babu buƙatar siyan na'urori daban daban don saka idanu akan yanayin lafiyar.
- Farashin na'urar yana da araha da ƙarancin ƙasa.
- Na'urar da kanta amintacciya ce mai dorewa.
Yawancin lokuta marasa lafiya suna amfani da mitut ɗin glucose na jini. Ya kamata a auna yara da matasa a ƙarƙashin kulawa na manya. Yayin nazarin, ya zama dole ya kasance nesa da abin da zai yiwu daga kayan lantarki, tunda zasu iya karkatar da sakamakon binciken.
Kallon karfin jini na Omelon
Wadannan masu lura da karfin jini a atomatik da kuma wadanda ba masu cin zalin jini ba sun kamu ne ta hanyar masana kimiyya daga Russia. An gudanar da aikin ci gaba na kayan aikin na dogon lokaci.
Kyakkyawan halayen na'urar da aka ƙera a Rasha sun haɗa da:
- Samun duk binciken da ake buƙata da gwaji, na'urar tana da lasisi mai inganci kuma an yarda da ita a kasuwannin likita.
- Ana ɗaukar na'urar a cikin sauki kuma mai dacewa don amfani.
- Na'urar na iya adana sakamakon binciken da aka yi kwanan nan.
- Bayan aiki, ana kashe mitirin glucose na jini ta atomatik.
- Babban ƙari shine daidaitaccen girman da ƙananan nauyin na'urar.
Akwai samfura da yawa a kasuwa, waɗanda aka fi sani kuma sanannun sune Omelon A 1 da Omelon B 2 tonometer-glucometer Ta amfani da misalin na biyu na na'urar, zaku iya la'akari da manyan halaye da ikon na'urar.
Mitoci marasa jini a cikin jini da kuma masu lura da karfin jini na atomatik na Omelon B2 suna ba mara lafiya damar saka idanu kan lafiyarsu, lura da tasirin wasu nau'ikan samfura a kan sukari na jini da hawan jini.
Babban halayen na'urar sun hada da:
- Na'urar zata iya aiki cikakke ba tare da gazawa ba har tsawon shekaru biyar zuwa bakwai. Maƙerin ya ba da garanti na shekara biyu.
- Kuskuren aunawa ba shi da ƙima, don haka mai haƙuri yana karɓar bayanan bincike sosai.
- Na'urar na iya adana sakamakon sabbin sakamako na ƙwaƙwalwa.
- Batura huɗun AA batura ce ta AA.
Sakamakon binciken matsa lamba da glucose ana iya samun shi da ƙirar a cikin allo na na'urar. Kamar Omelon A1, ana amfani da na'urar ta Omelon B2 sosai a gida kuma a asibiti. A yanzu, irin wannan mitometer-glucometer ba shi da analogues a duk duniya, an inganta shi tare da taimakon sabbin fasahohi kuma na'urar zamani ce.
Idan aka kwatanta da na’urori masu kama da haka, na’urar Omelon mara karfi wacce take dauke da halayen manya-manyan kwastomomi masu inganci da ingantaccen mai aiki, wanda ke bayar da gudummawa ga babban ingancin bayanan da aka samu.
Kit ɗin ya haɗa da na'urar tare da cuff da umarni. Kewayon ma'aunin karfin jini shine 4.0-36.3 kPa. Adadin kuskure na iya zama babu 0.4 kPa.
Lokacin auna bugun zuciya, kewayon daga kashi 40 zuwa 180 a minti daya.
Yin amfani da mitirin gulukos na jini
Na'urar ta shirya don amfani da awanni 10 bayan an kunna ta. Ana gudanar da nazarin alamun glucose da safe akan ɓoye ciki ko aan awanni bayan cin abinci.
Kafin fara aikin, mai haƙuri ya kamata ya kasance cikin yanayin annashuwa da kwanciyar hankali na aƙalla minti goma. Wannan zai daidaita karfin hauhawar jini, bugun jini da kuma numfashi. Ta hanyar kiyaye waɗannan ƙa'idodin ne kawai za'a iya samun ingantaccen bayanai. An kuma haramta shan sigari a ranar tashin gwajin.
Wani lokaci ana yin kwatancen tsakanin aikin na'urar da daidaitaccen glucometer.
A wannan yanayin, da farko, don sanin sukarin jini a gida, kuna buƙatar amfani da na'urar Omelon.
Mai amfani da likita sake dubawa
Idan kayi nazari a shafukan yanar gizo na dandalin tattaunawa da shafukan yanar gizo na likitanci ra'ayoyin masu amfani da likitoci game da sabuwar na'urar ta duniya, zaku iya samun duka ra'ayoyi masu kyau da marasa kyau.
- Yin bita mara kyau, a matsayin mai mulkin, an danganta shi da ƙirar ƙira ta waje, har ila yau wasu marasa lafiya sun lura da ɗan bambanci tare da sakamakon gwajin jini ta amfani da glucometer na al'ada.
- Sauran ra'ayoyin game da ingancin na'urar da ba mara mamaye ba ce. Marasa lafiya sun lura cewa lokacin amfani da na'urar, ba kwa buƙatar samun takamaiman ilimin likita. Kulawa da yanayin jikin ku na iya zama mai sauri da sauƙi, ba tare da halartar likitoci ba.
- Idan muka bincika samin sake dubawa na mutanen da suka yi amfani da na'urar Omelon, zamu iya yanke shawara cewa bambanci tsakanin gwajin gwaje-gwaje da bayanan na'urar bai wuce raka'a 1-2 ba. Idan kun auna glycemia akan komai a ciki, bayanan zasu kusa zama iri daya.
Hakanan, gaskiyar cewa yin amfani da mitir-mitamitus na jini ba ya buƙatar ƙarin sayan kwalliyar gwaji da lancets za'a iya sanya shi cikin ƙari. Ta amfani da glucometer ba tare da tsaran gwajin ba, zaka iya ajiye kuɗi. Marasa lafiya baya buƙatar yin huda da samfuran jini don auna sukarin jini.
Daga cikin abubuwanda basu dace ba, an lura da matsalar rashin amfani da na'urar kamar yadda za'a iya ɗauka. Mistletoe yana ɗaukar kimanin 500 g, saboda haka ba shi da wahala a ɗauka tare da kai don yin aiki.
Farashin na'urar yana daga 5 zuwa 9 dubu rubles. Kuna iya siyan sa a kowane kantin magani, kantin sayar da kaya na musamman, ko kantin kan layi.
An bayyana ka'idodin amfani da mita Omelon B2 a cikin bidiyon a cikin wannan labarin.